CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 80 enrolled
Drug / intervention
Placebo +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01033383
NCT01033383Phase 1Completed
CompareCT.gov

Pilot Study: Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents

Yale University·interventional·Posted Dec 16, 2009·Updated Aug 15, 2013

In Brief

A Phase 1 clinical trial evaluating Placebo and Cranberry Capsule for Bacteriuria. Completed, enrolled 80 participants across 14 sites.

Detailed Summary

This study will investigate whether there is a particular dose of cranberry capsules that is effective in preventing the occurrence of urinary tract infections in females at least 65 years of age or older who live in a nursing home and who have a history of urinary tract infections. The Yale research team will be enrolling 80 subjects in total over several nursing home locations within Connecticut.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBacteriuria
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA), National Center for Research Resources (NCRR)

Timeline

Phase 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 16, 2009
Enrollment StartDec 1, 2009
Primary CompletionOct 1, 2010
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 16.5 years ago

Interventions

Placebodietary

36 milligram (mg) placebo capsule taken before quiet hours of sleep (qhs).

Cranberry Capsuledietary

36 milligram (mg) cranberry capsule, taken before quiet hours of sleep (qhs).